This post was contributed by a community member. The views expressed here are the author's own.

Community Corner

NEW FRONTIER IN DISEASE RESEARCH: EPIGENETICS

EPIGENETICS AND CANCER RESEARCH

Featuring Dr. Alfredo Galvez, Lead Research Scientist, Center for Nutritional Genomics

Don't miss this seminar that will unveil one of the newest and most exciting approaches to addressing serious disease.

Dr. Galvez, a pioneer in the field of epigenetics, will be speaking in Garden Grove.  In 1996, Dr. Galvez first discovered the Lunasin peptide in the process of researching soy protein at the University of Berkley.

Dr. Galvez realized that this impressive natural peptide, found in miniscule quantities in soybeans, blocks cell division and effectively turns down the dimmer switch in our genetic material.  In other words, it makes cells less receptive to disease.

Lunasin was first investigated as a factor that might prevent cancer from dividing and multiplying.  The mechanism has been published in prestigious journals such as the Journal of Cancer Research.

Dr. Galvez also discovered that it was not just Lunasin, but also the ability to protect the peptide so that sufficient amounts could actually be absorbed once inside the body.  Developing the "bioactivity" of Lunasin opened doors for many more health benefits. 

One powerful mechanism of action resulting from bioactive Lunasin is the dramatic lowering of cholesterol.

Meet Dr. Galvez in person and learn of the additional discoveriess that have been uncovered regarding the Lunasin "bioactive" peptide. (www.lunasin.com)

Seminar is FREE

Call to RESERVE your seat:  B & V Associates  888-475-4548

We’ve removed the ability to reply as we work to make improvements. Learn more here

The views expressed in this post are the author's own. Want to post on Patch?